Search
for

    GlossaryBiologics (Biological Therapies)

    medications derived from living organisms to treat various diseases

    Biologics, also known as biological drugs or biopharmaceuticals, are a category of medications derived from living organisms, such as cells, tissues, or proteins. Unlike traditional chemical drugs, biologics are typically large, complex molecules that target specific components of the immune system or cellular processes, making them effective for treating conditions like autoimmune diseases, cancers, and certain types of alopecia.

    Related Terms

    Learn

    5 / 5 results

      learn Alfatradiol

      a synthetic estrogen used topically as an anti-androgen

      learn GHK-Cu

      a copper peptide showing promise in both regrowth and reversing gray hair

      learn Exosomes

      Microscopic delivery system that sends growth-promoting signals to hair follicles

      learn Follistatin

      glycoprotein that inhibits TGF-β and promotes hair growth by antagonizing activin

      learn HMI-115

      much-hyped research compound targeting prolactin receptor in scalp

    Research

    5 / 1000+ results

    Community Join

    5 / 145 results

      community blueprint is working so well it seems

      in Chat  540 upvotes 3 months ago
      The conversation discusses a person successfully using a combination of Minoxidil, finasteride, and other treatments for hair loss, resulting in significantly improved hair. Despite some criticism, many admire his dedication to health and anti-aging research.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 3 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.